Antiproliferative activity of the extract of Gleditsia sinensis fruit on human solid tumour cell lines

被引:42
作者
Chow, LMC [1 ]
Tang, JCO
Teo, ITN
Chui, CH
Lau, FY
Leung, TWT
Cheng, G
Wong, RSM
Wong, ILK
Tsang, KMS
Tan, WQ
Zhao, YZ
Lai, KB
Lam, WH
Guo, DA
Chan, ASC
机构
[1] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Hom, Hong Kong, Peoples R China
[2] Hong Kong Polytech Univ, Cent Lab, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
[5] Peking Univ, State Key Lab Nat & Biominet Drugs, Beijing 100871, Peoples R China
关键词
herbal drugs; tumour; apoptosis;
D O I
10.1159/000069713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The fruit extract of Gleditsia sinensis Lam. (GSE) is a traditional herbal medicine that is saponin-rich. However, its activity on solid tumour cell lines has never been demonstrated. Methods: The activity of GSE was demonstrated in four cancer cell lines (breast cancer MCF-7, MDA-MB231, hepatoblastoma HepG2 and oesophageal squamous carcinoma cell line SLMT-1) using MTT assay, anchorage-independent clonogenicity assay, DNA laddering and in situ cell death detection. Results: The mean MTT50 (the mean concentration of GSE to reduce MTT activity by 50%) ranged from 16 to 20 mug/ml of GSE. An anchorage-independent clonogenicity assay showed that all of the four solid tumour cell lines gradually lost their regeneration potential after treatment with GSE, DNA fragmentation and TUNEL analysis demonstrated that the action of GSE is both dose- and time course-dependent. Conclusions: Our results suggest that GSE has a cytotoxic activity and can induce apoptosis in human solid tumour cell lines. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:303 / 308
页数:6
相关论文
共 28 条
[1]   MAMMARY CARCINOGENESIS SUPPRESSION BY GINSENG TISSUE-CULTURE BIOMASS TINCTURE [J].
BESPALOV, VG ;
ALEKSANDROV, VA ;
DAVYDOV, VV ;
LIMARENKO, AY ;
MOLOKOVSKII, DS ;
PETROV, AS ;
SLEPYAN, LI ;
TRILIS, YG .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1993, 115 (01) :63-65
[2]   WHAT DO COMMERCIAL GINSENG PREPARATIONS CONTAIN [J].
CUI, J ;
GARLE, M ;
ENEROTH, P ;
BJORKHEM, I .
LANCET, 1994, 344 (8915) :134-134
[3]  
*HONG KONG CANC RE, 1993, CANC INC MORT HONG K, P12
[4]  
*HONG KONG CANC RE, 1993, CANC INC MORT HONG K, P17
[5]  
*JIANGS NEW MED CO, 1977, ZHONG YAO DA CI DIAN, P2198
[6]  
*JIANGS NEW MED CO, 1977, ZHONG YA DA CI DIAN, P1147
[7]  
*JIANGS NEW MED CO, 1977, ZHONG YA DA CI DIAN, P1145
[8]  
*JIANGS NEW MED CO, 1977, ZHONG YAO DA CI DIAN, P1144
[9]   Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells [J].
Kim, SE ;
Lee, YH ;
Park, JH ;
Lee, SK .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) :507-511
[10]   CHEMICAL STUDIES ON CRUDE DRUG PRECESSION .1. ON THE CONSTITUENTS OF GINSENG RADIX RUBRA [J].
KITAGAWA, I ;
YOSHIKAWA, M ;
YOSHIHARA, M ;
HAYASHI, T ;
TANIYAMA, T .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1983, 103 (06) :612-622